SCHEMBL23716941

SCHEMBL23716941

Oc1ccc(-c2ccnc3ccsc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.47
RPS6KA3 P51812 1/20 0.42
ESR1 P03372 3/20 0.41
ESR2 Q92731 2/20 0.41
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ACVR1 Q04771 1/20 0.38
TLR8 Q9NR97 1/20 0.37
AXL P30530 1/20 0.37
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23716942 0.75 CCNB2 (0.43) PDK1ESR1CCNB2CDK1CCNB1
SCHEMBL29468124 0.74 AXL (0.44) AXLMKNK1MKNK2PDPK1PARP1
SCHEMBL105581 0.74 AXL (0.44) AXLMKNK1MKNK2PDPK1PARP1
SCHEMBL25156828 0.70 KDR (0.38) RPS6KA3GSK3AGSK3BCDK5SMN1; SMN2
SCHEMBL29365872 0.69 AXL (0.40) MAPTAXLMKNK1MKNK2PDPK1
SCHEMBL22859602 0.69 AXL (0.40) MAPTAXLMKNK1MKNK2PDPK1
SCHEMBL27278122 0.68 BMP4 (0.57) PDK1ESR1NPC1MAPTSMN1; SMN2
SCHEMBL4773518 0.67 ADORA2A (0.39) ACVR1AXLMKNK1MKNK2PDPK1
SCHEMBL18388932 0.67 TOP1 (0.44) RPS6KA3CCNB2CDK1CCNB1GSK3A
SCHEMBL529894 0.67 PIK3CA (0.64) RPS6KA3CCNB2CDK1CCNB1GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3862348-A1 ISOINDOLINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2021-08-11 EP disclosed
CN-1688549-A Compound having TGF-beta inhibitory activity and medicinal composition containing the same KIRIN BREWERY (JP) 2005-10-26 CN disclosed